PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WSO-B vs. NVO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between WSO-B and NVO is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

WSO-B vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Watsco Inc (WSO-B) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
8.98%
-38.82%
WSO-B
NVO

Key characteristics

Sharpe Ratio

WSO-B:

1.21

NVO:

-0.84

Sortino Ratio

WSO-B:

2.00

NVO:

-1.07

Omega Ratio

WSO-B:

1.83

NVO:

0.86

Calmar Ratio

WSO-B:

2.67

NVO:

-0.68

Martin Ratio

WSO-B:

8.08

NVO:

-1.49

Ulcer Index

WSO-B:

4.22%

NVO:

21.32%

Daily Std Dev

WSO-B:

28.14%

NVO:

37.67%

Max Drawdown

WSO-B:

-61.63%

NVO:

-71.32%

Current Drawdown

WSO-B:

-3.77%

NVO:

-42.79%

Fundamentals

Market Cap

WSO-B:

$20.66B

NVO:

$366.23B

EPS

WSO-B:

$12.34

NVO:

$3.18

PE Ratio

WSO-B:

41.48

NVO:

26.23

PEG Ratio

WSO-B:

4.55

NVO:

1.20

Total Revenue (TTM)

WSO-B:

$7.62B

NVO:

$290.40B

Gross Profit (TTM)

WSO-B:

$2.02B

NVO:

$245.88B

EBITDA (TTM)

WSO-B:

$781.97M

NVO:

$148.56B

Returns By Period

In the year-to-date period, WSO-B achieves a -3.77% return, which is significantly lower than NVO's -2.65% return. Over the past 10 years, WSO-B has outperformed NVO with an annualized return of 19.59%, while NVO has yielded a comparatively lower 15.77% annualized return.


WSO-B

YTD

-3.77%

1M

8.92%

6M

8.98%

1Y

34.11%

5Y*

27.89%

10Y*

19.59%

NVO

YTD

-2.65%

1M

3.34%

6M

-38.82%

1Y

-29.99%

5Y*

23.31%

10Y*

15.77%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

WSO-B vs. NVO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WSO-B
The Risk-Adjusted Performance Rank of WSO-B is 8888
Overall Rank
The Sharpe Ratio Rank of WSO-B is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of WSO-B is 8080
Sortino Ratio Rank
The Omega Ratio Rank of WSO-B is 9898
Omega Ratio Rank
The Calmar Ratio Rank of WSO-B is 9494
Calmar Ratio Rank
The Martin Ratio Rank of WSO-B is 8989
Martin Ratio Rank

NVO
The Risk-Adjusted Performance Rank of NVO is 88
Overall Rank
The Sharpe Ratio Rank of NVO is 77
Sharpe Ratio Rank
The Sortino Ratio Rank of NVO is 1010
Sortino Ratio Rank
The Omega Ratio Rank of NVO is 1010
Omega Ratio Rank
The Calmar Ratio Rank of NVO is 99
Calmar Ratio Rank
The Martin Ratio Rank of NVO is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

WSO-B vs. NVO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Watsco Inc (WSO-B) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for WSO-B, currently valued at 1.21, compared to the broader market-2.000.002.001.21-0.84
The chart of Sortino ratio for WSO-B, currently valued at 2.00, compared to the broader market-4.00-2.000.002.004.006.002.00-1.07
The chart of Omega ratio for WSO-B, currently valued at 1.83, compared to the broader market0.501.001.502.001.830.86
The chart of Calmar ratio for WSO-B, currently valued at 2.67, compared to the broader market0.002.004.006.002.67-0.68
The chart of Martin ratio for WSO-B, currently valued at 8.08, compared to the broader market-10.000.0010.0020.0030.008.08-1.49
WSO-B
NVO

The current WSO-B Sharpe Ratio is 1.21, which is higher than the NVO Sharpe Ratio of -0.84. The chart below compares the historical Sharpe Ratios of WSO-B and NVO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
1.21
-0.84
WSO-B
NVO

Dividends

WSO-B vs. NVO - Dividend Comparison

WSO-B's dividend yield for the trailing twelve months is around 2.11%, more than NVO's 1.72% yield.


TTM20242023202220212020201920182017201620152014
WSO-B
Watsco Inc
2.11%1.97%2.32%3.39%2.49%2.97%3.53%4.14%2.72%2.42%2.36%1.87%
NVO
Novo Nordisk A/S
1.72%1.68%1.00%1.20%1.34%1.86%2.14%2.47%2.12%3.93%1.31%1.96%

Drawdowns

WSO-B vs. NVO - Drawdown Comparison

The maximum WSO-B drawdown since its inception was -61.63%, smaller than the maximum NVO drawdown of -71.32%. Use the drawdown chart below to compare losses from any high point for WSO-B and NVO. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-3.77%
-42.79%
WSO-B
NVO

Volatility

WSO-B vs. NVO - Volatility Comparison

The current volatility for Watsco Inc (WSO-B) is 11.19%, while Novo Nordisk A/S (NVO) has a volatility of 13.09%. This indicates that WSO-B experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
11.19%
13.09%
WSO-B
NVO

Financials

WSO-B vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Watsco Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab